Tag: Eosinophilic phenotype asthma

Sanofi, Regeneron report Dupixent FDA approval for asthma

Dupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the US Food and Drug Administration ... Read More